Hailong An

机构：Hebei University of Technology, Hebei University of Science and Technology, Research Institute for Innovation and Technology, Beijing Founder Electronics (China), Institute of Biophysics and Biomedical Engineering, Institute of Biophysics, Institute of Biophysics, Institut de Recherche et d’Innovation, OriginWater (China) · ORCID：0000-0001-7947-357X

发表论文 117 篇 · 总被引 1888 次 · h-index 26

代表论文

• Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy (2025 · Theranostics · 被引 78)
• Hypoxia Reversion and STING Pathway Activation through Large Mesoporous Nanozyme for Near-Infrared-II Light Amplified Tumor Polymetallic-Immunotherapy (2024 · ACS Nano · 被引 41)
• A large-pore mesoporous Au@Pt@Rh trimetallic nanostructure with hyperthermia-enhanced enzyme-mimic activities for immunomodulation-improved tumor catalytic therapy (2023 · Chemical Engineering Journal · 被引 26)
• NIR‐II Photothermal Activation of TRPV1 Channels for Intracellular Magnesium Regulation by Porous Pd@Pt Core–Shell Nanostructure to Reverse Tumor Multidrug Resistance (2023 · Advanced Functional Materials · 被引 23)
• A carrier-free ultrasound-responsive polyphenol nanonetworks with enhanced sonodynamic-immunotherapy for synergistic therapy of breast cancer (2025 · Biomaterials · 被引 19)
• Identification of a druggable pocket of the calcium-activated chloride channel TMEM16A in its open state (2023 · Journal of Biological Chemistry · 被引 16)